Question content area top

Part $1$

Ranbaxy$($India$)$ in Brazil.$$Ranbaxy$,$ an$$ India$-$based pharmaceutical$$ firm, has continuing problems with its cholesterol reduction$$ product's price in one of its rapidly growing$$ markets, Brazil. All product is produced in$$ India, with costs and pricing initially stated in Indian rupees$($Rps$),$ but converted to Brazilian reais$($R$$)$ for distribution and sale in Brazil. In$2009,$ the unit volume was priced at

Rps$22$ comma $10022,100,$

with a Brazilian reais price set at

$$R$$891891.$

But in$2010,$ the reais appreciated in value versus the$$ rupee, averaging

Rps$25\mathrm{.}9725\mathrm{.}97$

$=$ R$$1\mathrm{.}00.$ In order to preserve the reais price and product profit margin in$$ rupees, what should the new rupee price be set$$ at$?$